Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 30, 2019Proceedings of the National Academy of SciencesOpen Access

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAbhishek S. KashyapBoehringer Ingelheim (Egypt)MSMartina SchmittnaegelRoche Pharma AG (Germany)NRNicolò RigamontiVita-Salute San Raffaele University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kashyap et al. (2019) studied this question.

synapsesocial.com/papers/6a6fe1cd26a7f98052dc7435https://doi.org/10.1073/pnas.1902145116
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles2005 · 58,172 citations
  2. 2Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF2005 · 351 citations
  3. 3Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma2014 · 606 citations
  4. 4Toll-Like Receptor Signaling Pathways2014 · 3,319 citations
  5. 5Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity2018 · 222 citations